• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期黑色素瘤患者辅助使用伊匹木单抗治疗期间出现类似转移瘤的结节病样疾病:CT扫描和MRI有助于处理棘手的临床决策。

Sarcoidosis-like disease mimicking metastases during adjuvant ipilimumab therapy in advanced melanoma patient: CT scan and MRI help in managing difficult clinical decision.

作者信息

Garanzini Enrico Matteo, Scaramuzza Davide, Spadarella Gaia, Di Guardo Lorenza, Marchianò Alfonso

机构信息

Postgraduation School of Radiology, Università degli Studi di Milano, Milan, Italy.

Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

出版信息

BJR Case Rep. 2020 Sep 29;6(2):20190065. doi: 10.1259/bjrcr.20190065. eCollection 2020 Sep.

DOI:10.1259/bjrcr.20190065
PMID:33029362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7526996/
Abstract

The onset of an autoimmune, sarcoidosis-like reaction during or after treatment with immunomodulatory drugs as Ipilimumab is an atypical but renowned eventuality. Awareness of this scenario and its radiological features helps the Radiologist to avoid misdiagnosis of disease progression. In this case report, we present a patient operated for advanced cutaneous melanoma of the left forearm who developed hilar adenopathies with lung and splenic nodules during therapy with Ipilimumab in adjuvant setting. These findings were at first referred to as disease recurrences. Based on discrepancies between imaging, clinic and blood test findings we decided to put the patient on strict follow-up which showed a spontaneous complete regression on the visceral lesions few months after Ipilimumab withheld.

摘要

在用免疫调节药物(如伊匹单抗)治疗期间或之后出现自身免疫性结节病样反应是一种非典型但广为人知的情况。了解这种情况及其放射学特征有助于放射科医生避免对疾病进展的误诊。在本病例报告中,我们介绍了一名因左前臂晚期皮肤黑色素瘤接受手术的患者,该患者在辅助治疗中使用伊匹单抗期间出现肺门淋巴结肿大以及肺部和脾脏结节。这些发现起初被认为是疾病复发。基于影像学、临床和血液检查结果之间的差异,我们决定对该患者进行严格随访,结果显示在停用伊匹单抗几个月后,内脏病变出现自发性完全消退。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/82a168272e7a/bjrcr.20190065.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/331fbd79517c/bjrcr.20190065.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/b88ffbd688ff/bjrcr.20190065.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/f06876e533ab/bjrcr.20190065.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/2c15b38cc9bb/bjrcr.20190065.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/a0819623c9e0/bjrcr.20190065.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/82a168272e7a/bjrcr.20190065.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/331fbd79517c/bjrcr.20190065.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/b88ffbd688ff/bjrcr.20190065.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/f06876e533ab/bjrcr.20190065.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/2c15b38cc9bb/bjrcr.20190065.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/a0819623c9e0/bjrcr.20190065.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1794/7526996/82a168272e7a/bjrcr.20190065.g006.jpg

相似文献

1
Sarcoidosis-like disease mimicking metastases during adjuvant ipilimumab therapy in advanced melanoma patient: CT scan and MRI help in managing difficult clinical decision.晚期黑色素瘤患者辅助使用伊匹木单抗治疗期间出现类似转移瘤的结节病样疾病:CT扫描和MRI有助于处理棘手的临床决策。
BJR Case Rep. 2020 Sep 29;6(2):20190065. doi: 10.1259/bjrcr.20190065. eCollection 2020 Sep.
2
Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab.转移性黑色素瘤患者发生脾结节病样病变延迟,伊匹单抗治疗后获得长期临床缓解。
Oncoimmunology. 2014 Aug 3;3(8):e954506. doi: 10.4161/21624011.2014.954506. eCollection 2014.
3
Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission.抗程序性死亡蛋白1(PD-1)治疗后结节病,酷似一名处于完全缓解期的转移性黑色素瘤患者病情复发。
Rev Med Interne. 2018 Feb;39(2):130-133. doi: 10.1016/j.revmed.2017.11.008. Epub 2017 Dec 23.
4
Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy.伊匹单抗治疗后多个痣和黑色素瘤转移的同时持久消退。
Melanoma Res. 2019 Jun;29(3):311-312. doi: 10.1097/CMR.0000000000000555.
5
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.与检查点抑制剂相关的肉芽肿/类肉瘤样病变:黑色素瘤患者亚群中治疗反应的标志物。
J Immunother Cancer. 2018 Feb 12;6(1):14. doi: 10.1186/s40425-018-0323-0.
6
Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.免疫检查点抑制剂治疗后并发神经结节病的迟发性发作。
J Immunother Cancer. 2018 Jul 31;6(1):77. doi: 10.1186/s40425-018-0390-2.
7
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature.伊匹木单抗和纳武单抗联合免疫治疗背景下的结节病:一例病例报告及文献综述
J Immunother Cancer. 2016 Dec 20;4:94. doi: 10.1186/s40425-016-0199-9. eCollection 2016.
8
Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.免疫检查点抑制剂相关的类肉瘤样肉芽肿性炎症:在接受晚期恶性黑色素瘤治疗的患者的淋巴结细针抽吸细胞学中检测到的一种罕见不良事件。
Hum Pathol. 2019 Sep;91:69-76. doi: 10.1016/j.humpath.2019.07.001. Epub 2019 Jul 4.
9
New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment.转移性黑色素瘤患者接受 CTLA4 单克隆抗体治疗后新发纵隔和中枢神经系统结节病。
Oncol Res Treat. 2014;37(6):351-3. doi: 10.1159/000362614. Epub 2014 May 12.
10
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.辅助伊匹单抗对比安慰剂用于完全切除的高风险 III 期黑色素瘤(EORTC 18071):一项随机、双盲、III 期临床试验。
Lancet Oncol. 2015 May;16(5):522-30. doi: 10.1016/S1470-2045(15)70122-1. Epub 2015 Mar 31.

引用本文的文献

1
Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents.与靶向治疗和生物制剂相关的药物诱导的结节病样反应。
Diagnostics (Basel). 2025 Jun 29;15(13):1658. doi: 10.3390/diagnostics15131658.
2
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors.接受检查点抑制剂治疗的晚期实体瘤患者中的结节病样反应。
Oncologist. 2025 May 8;30(5). doi: 10.1093/oncolo/oyaf017.
3
Immune checkpoint blockade induced sarcoid-like reaction mimicking progression of disease in a patient with microsatellite instable colorectal cancer: case report and review of the literature.

本文引用的文献

1
Immune-related adverse events of immune checkpoint inhibitors: a brief review.免疫检查点抑制剂的免疫相关不良事件:简要综述。
Curr Oncol. 2018 Oct;25(5):342-347. doi: 10.3747/co.25.4235. Epub 2018 Oct 31.
2
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.癌症中的抗程序性死亡蛋白1(Anti-PD-1)和抗细胞毒性T淋巴细胞相关蛋白4(Anti-CTLA-4)疗法:作用机制、疗效及局限性
Front Oncol. 2018 Mar 28;8:86. doi: 10.3389/fonc.2018.00086. eCollection 2018.
3
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
免疫检查点阻断诱导类肉瘤样反应,酷似微卫星不稳定型结直肠癌患者的疾病进展:病例报告及文献复习
J Gastrointest Oncol. 2024 Feb 29;15(1):500-507. doi: 10.21037/jgo-23-435. Epub 2024 Jan 25.
4
Splenic sarcoid reaction mimicking metastases in patients after uterine cancer surgery: a report of two cases.子宫癌术后患者脾脏类肉瘤反应酷似转移瘤:两例报告
Surg Case Rep. 2023 Sep 20;9(1):167. doi: 10.1186/s40792-023-01753-1.
5
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.CTLA4和PD1阻断辅助治疗黑色素瘤后出现的肉芽肿性和类结节病样免疫相关不良事件:ECOG-ACRIN E1609和SWOG S1404 III期试验的联合分析及文献综述
Cancers (Basel). 2023 Apr 29;15(9):2561. doi: 10.3390/cancers15092561.
6
[F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy.[F]氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在接受免疫治疗的黑色素瘤患者评估中的应用
Diagnostics (Basel). 2023 Mar 4;13(5):978. doi: 10.3390/diagnostics13050978.
7
Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma.转移性肾细胞癌中疑似免疫检查点抑制剂诱导的肺部结节病反应
Clin Case Rep. 2022 Jul 11;10(7):e5960. doi: 10.1002/ccr3.5960. eCollection 2022 Jul.
8
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.黑色素瘤中与免疫检查点抑制剂相关的结节病样肉芽肿病
Cancers (Basel). 2022 Jun 14;14(12):2937. doi: 10.3390/cancers14122937.
9
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review.病例报告:一名非小细胞肺癌患者中与检查点抑制相关的肝结节病样反应及文献综述
Front Oncol. 2022 Mar 10;12:824308. doi: 10.3389/fonc.2022.824308. eCollection 2022.
与检查点抑制剂相关的肉芽肿/类肉瘤样病变:黑色素瘤患者亚群中治疗反应的标志物。
J Immunother Cancer. 2018 Feb 12;6(1):14. doi: 10.1186/s40425-018-0323-0.
4
Ipilimumab in melanoma.伊匹单抗治疗黑色素瘤
Expert Rev Anticancer Ther. 2016 Aug;16(8):811-26. doi: 10.1080/14737140.2016.1211936. Epub 2016 Jul 25.
5
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study.接受免疫检查点抑制剂治疗的黑色素瘤患者的系统性炎症:尸检研究。
J Immunother Cancer. 2016 Mar 15;4:13. doi: 10.1186/s40425-016-0117-1. eCollection 2016.
6
Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis.与抗CTLA-4抗体相关的免疫相关不良事件:系统评价与荟萃分析。
BMC Med. 2015 Sep 4;13:211. doi: 10.1186/s12916-015-0455-8.
7
From mice to humans: developments in cancer immunoediting.从小鼠到人类:癌症免疫编辑的进展
J Clin Invest. 2015 Sep;125(9):3338-46. doi: 10.1172/JCI80004. Epub 2015 Aug 4.
8
Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab.转移性黑色素瘤患者发生脾结节病样病变延迟,伊匹单抗治疗后获得长期临床缓解。
Oncoimmunology. 2014 Aug 3;3(8):e954506. doi: 10.4161/21624011.2014.954506. eCollection 2014.
9
Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management.与伊匹单抗CTLA-4阻断疗法相关的免疫介导不良事件:潜在机制与临床管理
Scientifica (Cairo). 2013;2013:857519. doi: 10.1155/2013/857519. Epub 2013 Apr 17.
10
Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor.转移性黑色素瘤患者序贯接受抗 CTLA-4 单克隆抗体和选择性 BRAF 抑制剂治疗后发生结节病。
Anticancer Res. 2012 Apr;32(4):1355-9.